An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

Summary

The purpose of this extension study is to collect additional safety and efficacy on QCZ484 for hypertensive patients who successfully completed the parent study, CQCZ484A12201 or additional QCZ484 studies as specified in the respective parent study protocols.

Timeline

Start

2026-05-07

Primary completion

2031-05-31

Completion

2031-11-30

Drugs

Indications